BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16335785)

  • 1. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
    Gupta SK; Saxena A; Singh U; Arya DS
    Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
    Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
    Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
    Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence.
    Goyal SN; Bharti S; Arora S; Golechha M; Arya DS
    Biomed Pharmacother; 2010 Nov; 64(9):639-46. PubMed ID: 20888175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
    Xia Z; Kuo KH; McNeill JH; Ansley DM
    Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
    Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
    Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
    Wang QD; Li XS; Lundberg JM; Pernow J
    Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury.
    Ozdemir R; Parlakpinar H; Polat A; Colak C; Ermis N; Acet A
    Toxicology; 2006 Feb; 219(1-3):142-9. PubMed ID: 16406210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeic acid phenethyl ester on short-term acute myocardial ischemia.
    Ince H; Kandemir E; Bagci C; Gulec M; Akyol O
    Med Sci Monit; 2006 May; 12(5):BR187-93. PubMed ID: 16641873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway.
    Guo Y; Li Z; Shi C; Li J; Yao M; Chen X
    Int J Mol Med; 2017 Oct; 40(4):999-1008. PubMed ID: 28849190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
    Wang X; Cheng Y; Xue H; Yue Y; Zhang W; Li X
    Fitoterapia; 2015 Sep; 105():16-25. PubMed ID: 26025856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thimerosal attenuates ischaemia-reperfusion arrhythmias in rats: no modification by anti-ischaemic agent trimetazidine or endothelin receptor antagonist bosentan.
    Iskit AB; Guc MO
    Pharmacol Res; 1996; 34(1-2):17-23. PubMed ID: 8981551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart.
    Dagassan PH; Breu V; Clozel M; Clozel JP
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):867-74. PubMed ID: 7898067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat.
    Li XS; Wang QD; Pernow J
    Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function.
    Ojha S; Golechha M; Kumari S; Bhatia J; Arya DS
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):219-27. PubMed ID: 21975080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.
    Gonon AT; Bulhak A; Bröijersén A; Pernow J
    Br J Pharmacol; 2005 Mar; 144(6):860-6. PubMed ID: 15685207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diosmin pretreatment improves cardiac function and suppresses oxidative stress in rat heart after ischemia/reperfusion.
    Senthamizhselvan O; Manivannan J; Silambarasan T; Raja B
    Eur J Pharmacol; 2014 Aug; 736():131-7. PubMed ID: 24769512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.